Acute-on-chronic liver failure (ACLF)
Protocol · GI / Surgical
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Acute deterioration of advanced chronic liver disease (≥F3/cirrhosis) with liver failure PLUS extrahepatic organ failure — very high short-term mortality, distinct from acute liver failure. Bacterial infection is the commonest trigger (also alcohol, HBV flare, drug injury, GI bleed). Core = liver failure (INR ≥1.5 AND bilirubin ≥5 mg/dL) PLUS ≥1 extrahepatic organ dysfunction/failure.
Assessment
Investigations
- Grade by number of extrahepatic organ failures (1 → ≥2); use ACLF scores (CLIF-C ACLF, AARC) serially rather than Child-Pugh/MELD
- Full septic screen on admission (ascitic tap, blood/urine/sputum cultures); U&E (AKI), ammonia (a normal level makes HE unlikely), lactate, coagulation (TEG/ROTEM reflects haemostasis better than INR)
- Organ-failure thresholds: AKI stage 2–3, HE grade 3–4 / GCS <12, vasopressor need, PaO₂/FiO₂ ≤225
Management
- Early appropriate antibiotics improve survival; treat the precipitant; balanced crystalloids (Ringer / Plasma-Lyte) over saline; albumin for defined indications (large-volume paracentesis, SBP, HRS-AKI), not routine resuscitation
- Noradrenaline first-line (MAP ≥65), vasopressin second; HE — lactulose ± rifaximin, intubate if GCS <9; lung-protective ventilation
- Do NOT prophylactically correct coagulopathy; short-acting sedation (avoid benzodiazepines); antivirals within 24 h for viral triggers
- Early transplant-centre assessment; corticosteroids for severe alcohol-related hepatitis but NOT in ACLF grade 3 (reassess with Lille at day 4/7)
Disposition
ICU for organ support + early transplant-centre referral — progressive multi-organ ACLF has very high mortality.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.